comprehensive -WSS

comprehensive

author：comprehensive 2025-09-28 13:26:10 - browse：155

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed scientific disclosures Monday, paving the way for its full approval but leaving physicians with lingering questions about the medicine’s impact on patients as a new era in Alzheimer’s therapy unfolds.

The drug, called donanemab, showed a 35% slowing of Alzheimer’s disease progression relative to placebo in a clinical trial that enrolled 1,700 patients with early-stage disease. Numerically, that’s a modest, 3.3-point improvement on a 144-point survey, called the Integrated Alzheimer’s Disease Rating Scale, or iADRS, that combines measures of cognition and function, such as driving, managing finances, or carrying on conversations.

There was a similar benefit when donanemab’s efficacy was assessed using a more common measure of cognition called the Clinical Dementia Rating-Sum of Boxes, or CDR-SB. On that scale, the Lilly drug showed a 36% slowing of cognitive decline relative to placebo, or 0.68 points on an 18-point scale.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

explore

knowledge

WSS

Cell therapy fails to slow type 1 diabetes, but safety is established

Cell therapy fails to slow type 1 diabetes, but safety is established

After traumatic brain injury, life support decisions can use more time

Exact Sciences stock tumbles despite strong cancer detection sales

Acelyrin, a rare IPO success, stumbles in its first big test

White House touts steps to stem shortages of cancer treatments

Wikipedia

comprehensive

hotspot

Guidelines to prevent youth baseball injuries need more muscle

After traumatic brain injury, life support decisions can use more time

ChatGPT in medicine: STAT answers readers' burning questions

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Trump demands the U.S. pay no more for drugs than other countries … again

Private equity could exacerbate cardiology's overuse problem, experts fear

Wildfire smoke exposes gaps in outdoor worker protections

More tobacco lobbyists active in statehouses

Continuity nursing helped my family in our darkest PICU moments

PEPFAR is under serious threat — and so is global health

hotspot

More tobacco lobbyists active in statehouses

Pig kidney works a record two months in donated body

UnitedHealth financials solid despite Change Healthcare cyberattack

Pig kidney works a record two months in donated body

A common UTI test for kids haunts adults as a traumatic 'nightmare'

H5N1 bird flu virus started spreading in cows in Texas in December

entertainment

explore

knowledge

hotspot